Cargando…
CRISPR/Cas9 for Cancer Therapy: Hopes and Challenges
Cancer is the second leading cause of death globally and remains a major economic and social burden. Although our understanding of cancer at the molecular level continues to improve, more effort is needed to develop new therapeutic tools and approaches exploiting these advances. Because of its high...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315587/ https://www.ncbi.nlm.nih.gov/pubmed/30424477 http://dx.doi.org/10.3390/biomedicines6040105 |